Assoc. Prof. Dr. Amir hossein Taromchi | Immunology | Best Researcher Award

Assoc. Prof. Dr. Amir hossein Taromchi | Immunology – Reearcher at Zanjan University of Medical Sciences, Iran

Dr. Amir Hossein Taromchi is an esteemed Associate Professor at Zanjan University of Medical Sciences (ZUMS), specializing in Medical Biotechnology and Nanotechnology within the Faculty of Medicine. With an extensive academic background, Dr. Taromchi has contributed significantly to the fields of molecular diagnostics, recombinant proteins, and gene therapy, particularly focusing on cancer research and the development of diagnostic and therapeutic biotechnologies. His journey in academia and research has allowed him to mentor numerous graduate students and lead various projects with profound clinical implications.

Profile Verified:

Orcid | Scopus | Google Scholar

Education:

Dr. Taromchi earned his Ph.D. in Medical Biotechnology from Shahid Beheshti University of Medical Sciences, Tehran, in 2013, where he was honored for his excellence in comprehensive exams. His research focused on the molecular cloning and expression of human IL-29 (IFN-λ1) in Iranian Lizard Leishmania, a critical contribution to understanding the molecular biology of infectious diseases. Prior to this, he obtained an M.Sc. in Medical Virology from Iran University of Medical Sciences and a B.Sc. in Microbiology Sciences from Islamic Azad University, Zanjan Branch. His academic credentials lay a strong foundation for his future work in molecular diagnostics and recombinant technology.

Experience:

Dr. Taromchi’s career spans over two decades, during which he has gained valuable research and teaching experience. He served as a research assistant at the Avecina Research Center and later worked on a variety of molecular diagnostics projects at the Karimi-Nejad-Najmabadi Genetics and Pathology Center in Tehran. His academic experience includes being a lecturer at Azad University, Zanjan, where he taught courses on virology, molecular biology, and biotechnology. At ZUMS, he continues to serve as both a researcher and educator, supervising a range of graduate theses focused on cutting-edge biotechnological innovations. Additionally, Dr. Taromchi is currently the head of the Cancer Gene Therapy Research Center, further cementing his role in advancing cancer biotechnology.

Research Interests:

Dr. Taromchi’s research interests are diverse, focusing primarily on molecular diagnostics, genetic disorders, and cancer therapeutics. He is particularly invested in the development of rapid molecular diagnostic tools for infectious diseases and human genetic disorders, including cancers. His work also explores recombinant protein expression, the development of vaccines, and the use of nanotechnology in medical applications, particularly in gene therapy and targeted drug delivery systems. These research areas highlight his commitment to improving healthcare through innovative biomedical solutions.

Awards:

Throughout his academic and research career, Dr. Taromchi has earned several accolades, including first rank in the PhD entrance examination for medical biotechnology. His excellence in research has earned him recognition in both national and international platforms. Furthermore, he has received numerous fellowships and distinctions, solidifying his standing as a leader in his field.

Publications:

Dr. Taromchi has authored several peer-reviewed articles and contributions to academic books, shedding light on key advancements in biotechnology and molecular diagnostics. Some notable publications include:

1. Taromchi A.H., Kazemi B., Mahmazi S., Bandehpour M. “Heterologous expression of human IL-29 (IFN-λ1) in Iranian Lizard Leishmania.” Iranian Journal of Biotechnology (2013). 📝

2. Taromchi A.H., Kariminejad R., Zanganeh M., Imanian H., Nayeb bagher T., Najmabadi H. “Multiplex reverse transcription polymerase chain reaction for simultaneous screening of 7 translocations.” Tashkhis Azmayeshghahi (2002). 📝

3. Gholinejad M., Abdanipour A., Taromchi A.H. “Adenosine decreases oxidative stress and protects H2O2-treated neural stem cells against apoptosis through decreasing Mst1 expression.” Biomedical Reports (2018). 📝

4. Dehghani S., Sabzehei F., Taromchi A.H., Mobaien A.R., Arsang-Jang S. “Hybrid recombinant Omp 22, 25, and 31 immunodominant epitopes can be used for serodiagnosis of brucellosis.” Journal of Immunological Methods (2021). 📝

Conclusion:

Dr. Amir Hossein Taromchi stands as a prominent figure in the realm of medical biotechnology, with an academic and research career spanning over 20 years. His work in molecular diagnostics, recombinant proteins, cancer gene therapy, and nanotechnology has not only earned him significant recognition but also contributed to the advancement of medical biotechnology in Iran and globally. Through his dedication to teaching, research, and innovation, Dr. Taromchi continues to inspire the next generation of biotechnologists, researchers, and medical professionals. His contributions to the field remain invaluable, particularly in the areas of molecular diagnostics and cancer therapeutics.